Compare CAKE & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAKE | LQDA |
|---|---|---|
| Founded | 1972 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.1B |
| IPO Year | 1996 | 2020 |
| Metric | CAKE | LQDA |
|---|---|---|
| Price | $61.75 | $35.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 10 |
| Target Price | ★ $59.47 | $38.90 |
| AVG Volume (30 Days) | 1.4M | ★ 1.7M |
| Earning Date | 05-21-2026 | 06-15-2026 |
| Dividend Yield | ★ 1.91% | N/A |
| EPS Growth | N/A | ★ 51.81 |
| EPS | ★ 3.06 | N/A |
| Revenue | ★ $3,751,806,000.00 | $158,320,000.00 |
| Revenue This Year | $6.16 | $208.46 |
| Revenue Next Year | $6.60 | $27.44 |
| P/E Ratio | $20.60 | ★ N/A |
| Revenue Growth | 4.75 | ★ 1031.18 |
| 52 Week Low | $43.00 | $11.26 |
| 52 Week High | $69.70 | $46.67 |
| Indicator | CAKE | LQDA |
|---|---|---|
| Relative Strength Index (RSI) | 49.58 | 51.21 |
| Support Level | $60.70 | $30.48 |
| Resistance Level | $64.56 | $36.07 |
| Average True Range (ATR) | 2.50 | 2.74 |
| MACD | -0.40 | 0.12 |
| Stochastic Oscillator | 31.06 | 76.72 |
The Cheesecake Factory Inc is a restaurant company that owns and operates multiple casual dining brands across the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.